Digital and Connected Health Devices
Industry Analysis, Expert Consulting and Surveys

Digital and Connected Health Devices Industry Overview

The global Digital and Connected Health Devices market is undergoing a significant transformation as healthcare providers, governments, and consumers increasingly embrace connected technologies to improve patient outcomes, reduce healthcare costs, and enable preventive care. Valued at approximately USD 112.8 billion in 2026, the market is projected to reach USD 265.4 billion by 2033, expanding at a CAGR of 13.0% during the forecast period. Growth is being driven by the rapid adoption of wearable medical devices, remote patient monitoring (RPM), Internet of Medical Things (IoMT), AI-powered diagnostics, digital therapeutics, and home healthcare solutions. Rising incidences of chronic diseases, aging populations, increasing smartphone penetration, and favorable reimbursement policies for remote healthcare services continue to accelerate global market expansion.

North America remains the largest regional market, supported by advanced healthcare infrastructure, widespread deployment of connected medical devices, high healthcare expenditure, and increasing integration of AI-enabled monitoring technologies into clinical workflows. Europe continues to strengthen its position through government-led digital health initiatives, stricter interoperability standards, and expanding investments in connected care ecosystems. Meanwhile, Asia-Pacific is expected to register the fastest growth through 2033, driven by rapid digitalization of healthcare, expanding telemedicine infrastructure, favorable government policies, growing middle-class populations, and increasing adoption of connected health devices across China, India, Japan, South Korea, and Southeast Asia. Latin America and the Middle East are also witnessing accelerated investments in digital healthcare platforms aimed at improving healthcare accessibility and reducing the burden on traditional healthcare systems.

The industry is evolving rapidly with the convergence of Artificial Intelligence (AI), machine learning, cloud computing, edge computing, 5G connectivity, and advanced biosensor technologies. Modern connected health devices including smartwatches, continuous glucose monitors (CGMs), connected ECG monitors, wearable cardiac monitors, smart inhalers, connected insulin pens, pulse oximeters, smart blood pressure monitors, and digital diagnostic devices—are enabling continuous real-time monitoring, early disease detection, and personalized treatment strategies. Healthcare providers are increasingly integrating these devices with electronic health records (EHRs), digital therapeutics, and predictive analytics platforms, creating a connected healthcare ecosystem capable of delivering more proactive, personalized, and value-based care.

The market is also witnessing a shift from standalone medical devices toward integrated digital health ecosystems that combine connected hardware, mobile health applications, cloud-based analytics, virtual consultations, and AI-assisted clinical decision support. Consumer demand for preventive healthcare, wellness monitoring, mental health tracking, and personalized fitness management continues to expand the addressable market beyond traditional clinical settings. Despite strong growth prospects, challenges including cybersecurity risks, patient data privacy, interoperability limitations, evolving regulatory frameworks, and reimbursement complexities remain key considerations for industry stakeholders. Nevertheless, continuous innovation in digital biomarkers, sensor technologies, and AI-powered healthcare solutions is expected to position Digital and Connected Health Devices as one of the fastest-growing segments within the global healthcare technology industry over the coming decade.

Top Countries Contributing in the Digital and Connected Health Devices Industry

The Digital and Connected Health Devices market is primarily led by countries with advanced healthcare infrastructure, strong digital ecosystems, high wearable adoption, favorable reimbursement policies, and significant investments in AI, IoT, and connected medical technologies. The United States continues to dominate the global market, while China and India are witnessing the fastest expansion due to increasing digital healthcare adoption and large patient populations. Europe remains a major innovation hub, supported by stringent regulatory frameworks and growing investments in remote patient monitoring and digital therapeutics.

United States

Market Size: USD 38.6 Billion (2026)

Country-Specific Insight:
The United States remains the world's largest market for digital and connected health devices, driven by widespread adoption of wearable medical devices, remote patient monitoring (RPM), AI-assisted diagnostics, and favorable reimbursement for virtual care. Healthcare providers are increasingly integrating connected devices into chronic disease management, cardiovascular monitoring, diabetes care, and hospital-at-home programs.

Country Dynamics

Drivers

• High healthcare expenditure
• Strong reimbursement for RPM services
• Rising prevalence of diabetes and cardiovascular diseases

Trends

• AI-powered wearable diagnostics
• Hospital-at-home expansion
• Integration with Electronic Health Records (EHR)

Restraints

• Cybersecurity concerns
• Data privacy regulations
• High device and implementation costs

Technology Focus

• AI diagnostics, Continuous Glucose Monitoring (CGM), smart ECG devices, IoMT platforms, cloud-connected healthcare ecosystems.

China

Market Size: USD 18.4 Billion (2026)

Country-Specific Insight:
China has become the second-largest market through rapid digitalization, government-backed healthcare reforms, domestic wearable manufacturing, and increasing adoption of AI-enabled healthcare platforms. Large investments in smart hospitals and connected home healthcare continue to drive market expansion.

Country Dynamics

Drivers

• Government digital healthcare initiatives
• Aging population
• Large domestic electronics manufacturing base

Trends

• AI-enabled diagnostics
• Smart hospitals
• Connected elderly care

Restraints

• Data security regulations
• Regional healthcare disparities

Technology Focus

• AI healthcare, IoT-enabled monitoring, smart wearables, cloud healthcare platforms.

Germany

Market Size: USD 7.9 Billion (2026)

Country-Specific Insight:
Germany leads the European market through strong medical device manufacturing, nationwide digital health programs, reimbursement for digital therapeutics, and high adoption of connected monitoring technologies. The Digital Healthcare Act (DVG) continues to accelerate innovation.

Country Dynamics

Drivers

• Government support for digital health
• Aging demographics
• Strong healthcare infrastructure

Trends

• Digital therapeutics (DiGA)
• AI-assisted diagnostics
• Remote patient monitoring

Restraints

• GDPR compliance requirements
• Integration challenges across legacy systems

Technology Focus

• Digital therapeutics, AI imaging, connected chronic disease management, secure health data exchange.

Japan

Market Size: USD 7.3 Billion (2026)

Country-Specific Insight:
Japan's super-aging society has accelerated demand for connected healthcare solutions, including remote monitoring, robotic healthcare, and AI-assisted elderly care. The country is a global leader in healthcare robotics and precision medical devices.

Country Dynamics

Drivers

• Rapid aging population
• Government healthcare modernization
• High technology adoption

Trends

• Elderly monitoring
• Smart rehabilitation
• Home healthcare expansion

Restraints

• High implementation costs
• Workforce shortages

Technology Focus

• Healthcare robotics, wearable sensors, AI monitoring, connected rehabilitation devices.

India

Market Size: USD 5.8 Billion (2026)

Country-Specific Insight:
India is among the fastest-growing connected health markets, supported by expanding digital health infrastructure, increasing smartphone penetration, government initiatives such as the Ayushman Bharat Digital Mission (ABDM), growing telemedicine adoption, and rising awareness of preventive healthcare. Affordable wearable devices and AI-enabled health platforms are accelerating adoption across both urban and semi-urban regions.

Country Dynamics

Drivers

• Government digital health initiatives
• Expanding telemedicine
• Rising chronic disease burden

Trends

• Affordable wearables
• AI-based diagnostics
• Digital health startups

Restraints

• Rural connectivity gaps
• Affordability challenges
• Data privacy awareness

Technology Focus

• Mobile health (mHealth), AI diagnostics, wearable monitoring, cloud-based health platforms.

United Kingdom

Market Size: USD 5.1 Billion (2026)

Country-Specific Insight:
The United Kingdom continues expanding digital healthcare through NHS digital transformation programs, increased adoption of remote patient monitoring, AI-enabled diagnostics, and virtual healthcare delivery models.

Country Dynamics

Drivers

• NHS digital transformation
• Increasing chronic disease prevalence
• Government funding

Trends

• Virtual wards
• Remote cardiac monitoring
• AI clinical decision support

Restraints

• Budget constraints
• Cybersecurity risks

Technology Focus

• Connected monitoring, AI diagnostics, wearable cardiac devices, telehealth integration.

South Korea

Market Size: USD 4.3 Billion (2026)

Country-Specific Insight:
South Korea combines advanced ICT infrastructure with high wearable adoption and strong semiconductor capabilities, positioning the country as a global innovator in connected healthcare devices and AI-enabled diagnostics.

Country Dynamics

Drivers

• High digital connectivity
• Government smart healthcare initiatives
• Strong electronics industry

Trends

• AI imaging
• Smart hospitals
• Digital biomarkers

Restraints

• Strict medical device approvals
• Data governance challenges

Technology Focus

• 5G healthcare, AI diagnostics, biosensors, wearable medical devices.

France

Market Size: USD 3.9 Billion (2026)

Country-Specific Insight:
France continues investing in connected healthcare infrastructure through national digital health programs, emphasizing chronic disease management, telemedicine, and interoperability between healthcare providers.

Country Dynamics

Drivers

• Government healthcare digitization
• Growing elderly population
• Preventive healthcare initiatives

Trends

• Connected chronic disease management
• AI radiology
• Digital patient engagement

Restraints

• Complex reimbursement pathways
• Regulatory compliance

Technology Focus

• Telehealth platforms, AI imaging, connected monitoring devices.

Canada

Market Size: USD 3.2 Billion (2026)

Country-Specific Insight:
Canada is experiencing robust growth through increasing adoption of remote patient monitoring, provincial digital health programs, AI-enabled diagnostics, and expanding virtual healthcare services across geographically dispersed populations.

Country Dynamics

Drivers

• Government digital health investments
• Remote healthcare demand
• Aging population

Trends

• Virtual care
• AI-assisted diagnostics
• Connected home healthcare

Restraints

• Rural infrastructure challenges
• Interoperability limitations

Technology Focus

• Remote patient monitoring, wearable diagnostics, cloud healthcare, AI-powered clinical support.

PESTEL Analysis of Digital and Connected Health Devices Industry

The Digital and Connected Health Devices market is significantly influenced by macroeconomic conditions, regulatory policies, healthcare investments, technological innovation, demographic changes, environmental sustainability, and evolving legal frameworks. Governments worldwide are prioritizing healthcare digitalization, while healthcare providers and technology companies continue investing in connected devices to improve patient outcomes, reduce healthcare costs, and enhance accessibility. The convergence of Artificial Intelligence (AI), the Internet of Medical Things (IoMT), cloud computing, and 5G connectivity is reshaping the industry, making connected healthcare an integral part of future healthcare delivery.

Political

Government policies promoting digital healthcare, telemedicine, and healthcare infrastructure modernization are major growth drivers for the industry. Countries including the United States, Germany, Japan, China, India, and the United Kingdom have introduced national digital health strategies that encourage the adoption of connected medical devices, remote patient monitoring, and AI-assisted diagnostics. Public investments in healthcare digitization, reimbursement programs for remote patient monitoring, and cross-border collaborations in digital health are accelerating market growth. However, geopolitical tensions, trade restrictions, semiconductor supply chain disruptions, and changing healthcare reimbursement policies may influence manufacturing costs and international market expansion.

Economic

Increasing healthcare expenditure, rising disposable incomes, and growing investments in healthcare technology continue to support market expansion. The increasing burden of chronic diseases, aging populations, and demand for home-based healthcare are encouraging hospitals, insurers, and healthcare providers to adopt connected monitoring solutions that reduce hospitalization costs and improve long-term disease management. Venture capital investments, mergers and acquisitions, and strategic partnerships between medical device manufacturers and technology companies are further stimulating innovation. Nevertheless, inflationary pressures, fluctuating component prices, global semiconductor shortages, and economic uncertainty may temporarily impact manufacturing costs and purchasing decisions.

Social

Growing consumer awareness regarding preventive healthcare, wellness monitoring, and personalized medicine has significantly increased demand for connected health devices. Patients are increasingly adopting wearable devices to monitor heart health, blood glucose, blood pressure, sleep quality, physical activity, and mental well-being. Aging populations across developed economies and increasing healthcare accessibility in emerging markets continue to expand the addressable customer base. The growing acceptance of virtual healthcare consultations, digital therapeutics, and home healthcare services has further accelerated consumer confidence in connected healthcare technologies. However, digital literacy gaps among elderly populations and concerns regarding data privacy continue to influence adoption rates.

Technological

Rapid technological innovation remains the strongest growth catalyst for the industry. Artificial Intelligence (AI), Machine Learning (ML), Internet of Medical Things (IoMT), cloud computing, edge computing, 5G connectivity, digital twins, and advanced biosensor technologies are transforming connected healthcare ecosystems. Modern wearable devices now provide continuous monitoring of cardiac rhythms, blood oxygen levels, glucose levels, sleep disorders, respiratory conditions, and stress indicators with increasing clinical accuracy. Integration with Electronic Health Records (EHRs), predictive analytics, and AI-assisted clinical decision support systems is improving personalized treatment and enabling proactive healthcare management. Continuous innovation in battery technology, miniaturized sensors, and non-invasive monitoring devices is expected to further strengthen market growth over the coming decade.

Environmental

Sustainability has become an increasingly important consideration for connected health device manufacturers. Companies are investing in energy-efficient manufacturing processes, recyclable materials, reduced electronic waste, and environmentally responsible packaging solutions. Connected healthcare also contributes indirectly to environmental sustainability by reducing unnecessary hospital visits, minimizing travel-related emissions through telemedicine, and enabling remote patient monitoring. However, the growing volume of electronic waste generated by wearable devices, batteries, and connected sensors presents ongoing environmental challenges that require improved recycling infrastructure and circular economy initiatives.

Legal

The market operates within a highly regulated environment governed by medical device approvals, cybersecurity standards, patient privacy regulations, and interoperability requirements. Regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and national health authorities continue strengthening oversight for AI-enabled medical devices, Software as a Medical Device (SaMD), and connected monitoring systems. Compliance with data protection regulations such as HIPAA in the United States and GDPR in Europe remains essential for manufacturers and healthcare providers handling sensitive patient information. Additionally, evolving standards for cybersecurity, cross-border health data exchange, AI transparency, and digital health certification are expected to shape future product development and global market expansion.

Leading Manufacturers in the Digital and Connected Health Devices Industry

The Digital and Connected Health Devices market is highly competitive, with global medical technology companies, digital health innovators, and consumer electronics manufacturers investing heavily in artificial intelligence (AI), remote patient monitoring (RPM), wearable biosensors, cloud-based healthcare platforms, and Internet of Medical Things (IoMT) ecosystems. Companies are increasingly focusing on strategic acquisitions, AI-enabled healthcare solutions, software integration, and continuous innovation to strengthen their competitive position and expand recurring digital health revenue streams.

Medtronic plc

Revenue: USD 32.36 Billion (FY2025) → USD 33.2 Billion (Estimated FY2026)

R&D Investment: Approximately USD 2.8 Billion annually

Key Segment: Remote patient monitoring, cardiac rhythm management, diabetes management, connected surgical technologies

Market Share: Approximately 8.5% of the global digital and connected health devices market

Strengths:

• Global leader in connected cardiac care
• AI-enabled insulin pump ecosystem
• Strong hospital partnerships
• Advanced remote patient monitoring portfolio

Abbott Laboratories

Revenue: USD 42.0 Billion (2025) → USD 44.1 Billion (Estimated 2026)

R&D Investment: Approximately USD 3.0 Billion annually

Key Segment: Continuous Glucose Monitoring (CGM), cardiovascular monitoring, connected diagnostics

Market Share: Approximately 7.8%

Strengths:

• Market-leading FreeStyle Libre ecosystem
• Strong diabetes care portfolio
• Expanding digital diagnostics
• Global distribution network

DexCom Inc.

Revenue: USD 4.6 Billion (2025) → USD 5.2 Billion (Estimated 2026)

R&D Investment: Approximately USD 0.75 Billion annually

Key Segment: Continuous Glucose Monitoring (CGM)

Market Share: Approximately 4.5%

Strengths:

• Industry-leading real-time glucose monitoring
• AI-powered diabetes analytics
• Strong integration with smartphones and insulin delivery systems
• High recurring revenue model

GE HealthCare Technologies Inc.

Revenue: USD 20.9 Billion (2025) → USD 22.1 Billion (Estimated 2026)

R&D Investment: Approximately USD 1.4 Billion annually

Key Segment: Connected imaging, AI diagnostics, remote patient monitoring

Market Share: Approximately 5.5%

Strengths:

• AI-enabled imaging platforms
• Cloud-connected hospital infrastructure
• Strong enterprise healthcare ecosystem
• Advanced predictive analytics

Koninklijke Philips N.V.

Revenue: USD 19.4 Billion (2025) → USD 20.2 Billion (Estimated 2026)

R&D Investment: Approximately USD 2.0 Billion annually

Key Segment: Connected patient monitoring, sleep therapy, telehealth solutions

Market Share: Approximately 5.2%

Strengths:

• Comprehensive connected care platform
• Strong hospital monitoring solutions
• Digital ICU technologies
• Integrated telehealth ecosystem

Masimo Corporation

Revenue: USD 2.2 Billion (2025) → USD 2.5 Billion (Estimated 2026)

R&D Investment: Approximately USD 0.30 Billion annually

Key Segment: Pulse oximetry, wearable patient monitoring, remote monitoring

Market Share: Approximately 2.8%

Strengths:

• Industry-leading pulse oximetry technologies
• Hospital-grade wearable monitoring
• Continuous patient surveillance
• AI-powered monitoring solutions

Omron Healthcare Co., Ltd.

Revenue: USD 1.4 Billion (2025) → USD 1.5 Billion (Estimated 2026)

R&D Investment: Approximately USD 0.18 Billion annually

Key Segment: Connected blood pressure monitors, ECG devices, home healthcare

Market Share: Approximately 2.3%

Strengths:

• Global leader in home blood pressure monitoring
• Strong consumer healthcare brand
• Connected cardiovascular monitoring
• Expanding digital hypertension management

Boston Scientific Corporation

Revenue: USD 18.1 Billion (2025) → USD 19.2 Billion (Estimated 2026)

R&D Investment: Approximately USD 1.6 Billion annually

Key Segment: Cardiac monitoring, electrophysiology, connected implantable devices

Market Share: Approximately 4.2%

Strengths:

• Advanced implantable cardiac technologies
• AI-assisted cardiovascular diagnostics
• Strong electrophysiology portfolio
• Global hospital presence

Garmin Ltd.

Revenue: USD 7.3 Billion (2025) → USD 7.9 Billion (Estimated 2026)

R&D Investment: Approximately USD 0.75 Billion annually

Key Segment: Health wearables, wellness monitoring, fitness tracking

Market Share: Approximately 2.6%

Strengths:

• Advanced health analytics
• Multi-sensor wearable platform
• Long battery life
• Strong sports and wellness ecosystem

Apple Inc. (Health Devices Division)

Revenue (Health & Wearables Segment): Estimated USD 44.5 Billion (2025) → USD 48.2 Billion (Estimated 2026)

R&D Investment: More than USD 34 Billion company-wide annually, with significant investment directed toward digital health technologies.

Key Segment: Smartwatches, ECG monitoring, health sensors, wellness ecosystem

Market Share: Approximately 10–12% of the global connected health wearables segment

Strengths:

• Largest connected wearable ecosystem globally
• Advanced ECG and irregular rhythm detection
• Strong HealthKit integration
• AI-powered wellness analytics
• High consumer engagement and recurring ecosystem revenue

Recent Developments in the Digital and Connected Health Devices Industry

In June 2026, the U.S. Food and Drug Administration (FDA) cleared the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged two years and older. The approval expanded access to non-prescription glucose monitoring technology, enabling earlier detection and management of glucose-related health conditions while supporting the broader shift toward preventive and consumer-driven healthcare. The decision is expected to accelerate adoption of connected glucose monitoring devices in both pediatric and home healthcare settings.

In June 2026, the FDA authorized the latest version of the Dexcom G7 Continuous Glucose Monitoring System, including the 15-day CGM platform. The approval enhances sensor longevity, strengthens remote patient monitoring capabilities, and supports broader integration with digital health ecosystems and automated diabetes management solutions. The development reinforces the growing role of AI-enabled continuous monitoring technologies in connected healthcare.

In January 2026, Abbott announced a strategic partnership with Withings at CES 2026 to integrate Abbott's over-the-counter Lingo continuous glucose monitor with the Withings health platform. The collaboration allows users to seamlessly access glucose data alongside cardiovascular, sleep, activity, and metabolic health metrics within a unified digital ecosystem. The partnership reflects the industry's growing focus on integrated consumer health platforms and personalized wellness management.

Conclusion

The Digital and Connected Health Devices market is expected to witness strong long-term growth as healthcare increasingly shifts toward preventive, personalized, and digitally connected care. Advancements in Artificial Intelligence (AI), the Internet of Medical Things (IoMT), 5G, cloud computing, and advanced biosensors will enable smarter connected devices capable of real-time monitoring, early disease detection, and predictive healthcare.

Remote patient monitoring, AI-powered wearables, and home healthcare solutions will continue to gain momentum, particularly for managing chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions. Integration with Electronic Health Records (EHRs), telemedicine platforms, and digital therapeutics will further improve care coordination and patient outcomes.

Emerging economies, supported by expanding digital health infrastructure and government initiatives, are expected to drive significant future demand. As innovation accelerates and connected healthcare ecosystems mature, companies offering secure, interoperable, and clinically validated digital health solutions will be well positioned to capitalize on the market's long-term growth opportunities.